The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore - Wikidata - awgldk - TriplyDB

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore

http://www.wikidata.org/entity/Q33869565

about

Many stimuli pull the necrotic trigger, an overview An outline of necrosome triggers Fueling the flames: Mammalian programmed necrosis in inflammatory diseases Regulated necrotic cell death: the passive aggressive side of Bax and Bak The role of necroptosis in neurosurgical diseases The NAD-dependent deacetylase SIRT2 is required for programmed necrosis Necrostatin-1 rescues mice from lethal irradiation Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis.Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia.Protein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis.Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI.RIP kinases: key decision makers in cell death and innate immunity.The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.High-fat diet-induced adipocyte cell death occurs through a cyclophilin D intrinsic signaling pathway independent of adipose tissue inflammation Cardiomyocyte death: mechanisms and translational implications Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death.Using Small Molecules to Dissect Non-apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis.NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells.Past, present, and future of molecular and cellular oncology Programmed Necrosis: A Prominent Mechanism of Cell Death following Neonatal Brain Injury The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis.Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice Mechanisms of cell death in heart disease.Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke.Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease.Neuronal cell death in neonatal hypoxia-ischemia.Necroptosis, necrostatins and tissue injury.Necroptosis: biochemical, physiological and pathological aspects.Cell death in the myocardium: my heart won't go on.Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.TNF-α-induced programmed cell death in the pathogenesis of acquired aplastic anemia.Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.Necroptotic cell death in failing heart: relevance and proposed mechanisms.Expression and reconstitution of the bioluminescent Ca(2+) reporter aequorin in human embryonic stem cells, and exploration of the presence of functional IP3 and ryanodine receptors during the early stages of their differentiation into cardiomyocyte Evidence of necroptosis in hearts subjected to various forms of ischemic insults.The in vivo evidence for regulated necrosis.Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine.

P2860

Q24613714-CF3338B0-7563-4DB5-883C-26BD7071B3EB Q26751108-17FDFB33-868D-4FA8-80D4-EE530333194B Q26830515-C094B5BD-67F9-4924-809D-67C71CC97D25 Q27021740-2FFCA214-750C-425B-9D13-3D11A363FFBE Q28083902-4CC07E4E-ACDE-4A9C-AEAF-13BEF52E6273 Q28115154-43DE83AD-DF92-42E2-AEBB-34C91FBA2FF9 Q28389478-26A85666-F51B-44F9-AA69-714429ACA39D Q30009153-F0DE5539-3BF9-40BC-9DCC-4ECE89DC6562 Q33570328-68938122-BF26-4426-B11A-AA4D27988161 Q33604010-A821BF6E-1EF4-4F5A-B138-CD37237C0367 Q34252212-0A90BEAE-BA02-45F4-B78A-E241885AC27E Q34627513-897B6FD4-79F0-4C56-ACB9-0B7AB94FCD64 Q34924104-B5961E78-E9AC-48DA-9FC6-C322CE33F692 Q35038704-78F40D6D-6B5B-4D9E-B914-B4AA9E94F604 Q35123520-75599209-ECBF-4B2F-8DE7-3A961FBF43C2 Q35657122-97A54FD9-D1BD-44E3-AA7D-3BB356669E02 Q35659441-90417B5E-DC58-4F0A-A880-8B499F2AA829 Q35781653-CC949C0E-ED5A-4FD0-BF2F-2D293F3244C0 Q35832660-99535E10-4CB2-4BF1-AE1E-1EA04331915D Q35972276-02BB22D0-B86F-4E87-85F6-A734B1D862EA Q35994637-CA733B10-4B82-421B-8A3C-9AF7F3351827 Q36394948-0BCECB2D-997A-4A9A-993A-6A4637C46150 Q36525166-83BC42D9-5FE1-4BA0-9D11-A678CEFAAC6F Q37250709-705728F1-F56B-48E9-A5F3-DC905A229D9C Q37330076-FB48520B-E2B3-482C-ACD8-D17D51F4ADAE Q37350004-D2DF6AED-5C60-43DD-BFDE-1661DB58043C Q37631323-5DBEA816-1B99-4A78-9679-EAC0CE035A06 Q37686255-81DF2904-6B6B-4425-8631-A590371F35B6 Q37724332-16CBE586-DB1B-4B93-9D5B-E5FD47D4CC2D Q37874707-39CFC67A-485F-4149-8009-D5950840DC84 Q37902989-15DB3B05-0221-4EF6-8793-C0BB65234EB3 Q38119187-9EC2AEA0-AA95-407E-8C6D-E845CD026792 Q38370240-CE16E957-5241-49BD-88A1-F2B31DB49084 Q38543416-3B697700-9945-46F7-BBD6-D3CBE5163E93 Q38699105-17565627-2632-4343-A937-1A9300C6E918 Q38731479-651EF890-4408-4F26-B781-22900FD198FA Q38757346-0DC36B69-D51A-4D19-ABDB-7DF10F338649 Q38803858-9D629106-4DC9-471B-BB7D-A9E03FFCA5DD Q38809791-5FDB33FC-C0B9-4514-9119-B6896CA9C439 Q38861198-649E0739-FD19-4353-960F-CE704501B38E

P2860

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore

http://www.wikidata.org/entity/Q33869565

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The cardioprotective effect of ...... l permeability transition pore

@ast

The cardioprotective effect of ...... l permeability transition pore

@en

type

label

The cardioprotective effect of ...... l permeability transition pore

@ast

The cardioprotective effect of ...... l permeability transition pore

@en

prefLabel

The cardioprotective effect of ...... l permeability transition pore

@ast

The cardioprotective effect of ...... l permeability transition pore

@en

P1433

Q33869565-D27E87D5-1FBD-4A34-B534-3F55372F5593

P1476

Q33869565-FD8481DB-20E3-4C53-99D9-DC4C70A97215

P2093

Q33869565-20ED6A4E-0EC5-49C3-90B0-B4DD34DC2CFF

Q33869565-239B94E8-A053-41A2-951C-E842E07E5238

Q33869565-3FE8F56A-E156-4FA6-87C6-DD2160FE7006

Q33869565-B047B4B3-0E94-4B37-A36F-0AC807D2D634

Q33869565-B7989F62-14AA-496E-8CDB-08E1490BA24D

P2860

Q33869565-1C6E9458-B965-4C7F-9F32-EA6C2430B2AE

Q33869565-1E47CFB2-EB20-4D69-9879-EDC23930EC26

Q33869565-2F0207D9-715E-45D0-97F6-0EE7FD75A958

Q33869565-3DC79EE5-C41D-4E86-A723-7F1E863ED76A

Q33869565-489C4A6B-5493-4290-BAEC-BCECFEEF69E7

Q33869565-594C782A-9C52-4A31-93E7-64C160302DF9

Q33869565-7494AC6E-C259-4764-B10E-321B01C25C40

Q33869565-977B6FCD-9A7D-4381-893E-A4114065CBBD

Q33869565-98C202A8-7DF6-46B6-9C55-F3EED7F6C5BD

Q33869565-B9A792F2-2CC9-44D1-97E5-3F30BD0A8BD3

P304

Q33869565-385F24CE-5FA0-47ED-BA20-B677F589938B

P31

Q33869565-FD2DA52F-B787-41FB-95E5-A5FC7911F5D9

P356

Q33869565-3AB5BB22-CFC8-49A6-98B5-8202D8190382

P433

Q33869565-8F9FB4CB-08A8-498C-B3B4-4CE45133E0F4

P478

Q33869565-F9904B00-C558-46D0-A88A-8A3868BA91D5

P577

Q33869565-76E5A754-407E-4EF3-9F3D-863C5634D13C

P5875

Q33869565-98A7B2F1-9C74-4574-90E9-15A9D8B7E035

P698

Q33869565-FA87EECB-ACAC-4AE5-A5FA-EE938882C70D

P932

Q33869565-FEC2E570-9553-445A-9431-287667C92506

P356

S10557-007-6067-6

P1433

Cardiovascular Drugs and Therapy

P1476

The cardioprotective effect of ...... l permeability transition pore

@en

P2093

C C T Smith

http://www.w3.org/2001/XMLSchema#string

D M Yellon

http://www.w3.org/2001/XMLSchema#string

M M Mocanu

http://www.w3.org/2001/XMLSchema#string

S M Davidson

http://www.w3.org/2001/XMLSchema#string

S Y Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.

Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D.

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

Preconditioning and postconditioning: united at reperfusion.

Necrostatin: a potentially novel cardioprotective agent?

Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion.

P304

467-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-007-6067-6

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5880048

http://www.w3.org/2001/XMLSchema#string

P698

17965927

http://www.w3.org/2001/XMLSchema#string

P932

2874660

http://www.w3.org/2001/XMLSchema#string